| Symbol | Pop Rdy | Conf. | 15m | 30m | 1h | 4h | Price | Next Earn |
|---|---|---|---|---|---|---|---|---|
AMBQ |
70 | ×4 | Strong Close | Strong Close | Strong Close | Strong Close | $63.01 | 2026-11-05 |
AOSL |
68 | ×4 | Hammer | Strong Close | Strong Close | Hammer | $28.38 | 2026-11-09 |
BLZE |
66 | ×4 | Strong Close | Strong Close | Strong Close | Hammer | $19.19 | 2026-11-05 |
RXRX |
55 | ×4 | Strong Close | Strong Close | Strong Close | Strong Close | $3.1 | 2026-11-04 |
BTDR |
91 | ×3 | · | Strong Close | Strong Close | Hammer | $9.005 | 2026-11-09 |
NXE |
58 | ×3 | · | Bull Engulf | Bull Engulf | Strong Close | $10.26 | 2026-11-03 |
CDNL |
86 | ×2 | Hammer | · | · | Strong Close | $45.04 | 2026-11-12 |
APLD |
79 | ×2 | · | Bull Engulf | Bull Engulf | · | $28.505 | 2026-10-08 |
ACHR |
71 | ×2 | · | Strong Close | Strong Close | · | $6.315 | 2026-11-05 |
CAPR |
97 | ×1 | · | · | · | Hammer | $7.0826 | 2026-11-10 |
ONDS |
94 | ×1 | Bull Engulf | · | · | · | $9.06 | 2026-11-12 |
| Symbol | Live | Spike | Pop | RVol | Gap | VWAP | Open | Price | 1D% | ATR% | News |
|---|---|---|---|---|---|---|---|---|---|---|---|
CDNL |
69 | 88 | 86 | 1.7 | 6.1% | ▲ | 8.2% | $45.04 | +14.78% | 12.2% | |
ONDS |
64 | 91 | 94 | 1.2 | -4.7% | ▲ | 5.6% | $9.06 | +0.67% | 7.7% | |
PATH |
59 | 99 | — | 2.3 | -3.9% | ▼ | 1.3% | $15.59 | -2.62% | 5.8% | |
SMCI |
59 | 97 | — | 0.8 | -3.0% | ▲ | 0.8% | $37.41 | -2.26% | 6.7% | |
BTDR |
57 | 95 | 91 | 0.6 | -4.1% | ▲ | -0.2% | $9.01 | -4.25% | 13.3% | |
CIEN |
57 | 95 | — | 1.1 | -5.3% | ▲ | -3.8% | $405.73 | -8.89% | 8.2% | |
TER |
57 | 96 | — | 1.0 | -5.4% | ▲ | -3.7% | $403.79 | -8.88% | 7.3% | |
ACHR |
54 | 82 | 71 | 0.7 | -3.5% | ▲ | 2.4% | $6.32 | -1.25% | 8.5% | |
RCAT |
54 | 86 | 88 | 1.7 | -5.6% | ▼ | 3.6% | $10.20 | -2.16% | 8.6% | |
WDC |
54 | 97 | — | 0.8 | -7.5% | ▼ | 0.0% | $496.00 | -7.46% | 9.3% | |
MRAM |
53 | 94 | 95 | 1.1 | -6.8% | ▼ | -0.4% | $18.43 | -7.18% | 8.6% | |
MRVL |
52 | 97 | — | 1.0 | -5.8% | ▼ | -2.1% | $216.03 | -7.81% | 7.8% | |
IONQ |
51 | 94 | — | 0.9 | -5.3% | ▼ | -0.6% | $44.11 | -5.85% | 6.8% | |
AOSL |
50 | 74 | 68 | 1.4 | -6.0% | ▲ | -2.9% | $28.38 | -8.66% | 9.7% | |
COHR |
50 | 98 | — | 1.1 | -7.5% | ▼ | -5.7% | $306.12 | -12.78% | 12.7% |
| Symbol | Pop Rdy | Heat | RVol | Entry | Stop | 2R | 3R | Last | R now |
|---|---|---|---|---|---|---|---|---|---|
CDNL |
86 | 97 | 1.66× | $42.9 | $40.71 -5.1% | $47.27 | $49.46 | $45.04 | 0.98R |
| Symbol | Pop Rdy | Heat | RVol | Entry | Last | To entry |
|---|---|---|---|---|---|---|
PATH |
99 | 88 | 2.33× | $15.89 | $15.59 | 1.89% |
RCAT |
88 | 81 | 1.65× | $10.96 | $10.2 | 7.36% |
| Symbol | Entry $ | Now $ | 1D% | Return | % Off Hi | Vol (M) | RVOL | ATR% | Industry | First Source | State | First Seen | Days | Catalyst | Removed Reason | News | ML % | Spike | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLZE |
$7.22 | $19.20 | -0.98% | +165.9% | -8.2% | 2.1M | 0.7x | 10.9% | Software - Infrastructure | Track D | removed | 2026-05-07 | 104 | — | — | 📰 | 20% | 68 C49 · M96 · E25 · H12 | 2026-11-05 · 78d |
ERAS |
$10.64 | $18.10 | -0.98% | +70.1% | -5.8% | 1.8M | 0.6x | 5.5% | Biotechnology | featured-tier-2 | removed | 2026-05-07 | 104 | ● on deck Phase 1 ERAS-0015 monotherapy data (mid-May 2026 readout effectively played out — Apr 27 preliminary positive); next binary catalysts: ERAS-0015 combo dose-escalation data + ERAS-4001 Phase 1 (pan-KRAS) preliminary data H2 2026; Merck KEYTRUDA combo collaboration signed May 2026 2026-09-30 |
Auto-graduated 2026-07-01: ran +65% from pivot $11.0 -> $18.17. Original: RAS-pathway oncology. Phase 1 readout in 1-2 weeks. 62% NSCLC RR is the headline | 📰 | 20% | 4 C100 · M34 · E81 · H32 HOLDS | 2026-11-11 · 84d |
ATRC |
$28.81 | $45.76 | +2.21% | +58.8% | -1.2% | 0.9M | 1.0x | 3.7% | Medical Instruments & Supplies | Track A | removed | 2026-05-27 | 84 | — | — | 📰 | — | 31 C61 · M94 · E8 · H77 FADES | 2026-10-27 · 69d |
TENB |
$25.82 | $36.34 | +2.98% | +40.7% | -9.6% | 1.3M | 0.4x | 6.6% | Software - Infrastructure | Track A | active | 2026-05-27 | 84 | — | — | 📰 | — | 17 C64 · M58 · E14 · H3 HOLDS | 2026-10-28 · 70d |
ALKT |
$14.59 | $20.14 | -0.35% | +38.0% | -4.3% | 1.3M | 1.0x | 4.0% | Software - Application | Track D | active | 2026-06-23 | 57 | — | — | 📰 | — | 19 C78 · M77 · E14 · H56 FADES | 2026-10-28 · 70d |
AAOI |
$97.82 | $131.41 | -15.16% | +34.3% | -18.4% BOUNCE ZONE | 14.3M | 1.1x | 13.5% | Communication Equipment | Track H | active | 2026-07-28 | 22 | — | — | 📰 | — | 97 C47 · M78 · E58 · H92 FADES | 2026-11-05 · 78d |
BILL |
$37.66 | $49.17 | +1.38% | +30.6% | -6.5% | 2.4M | 1.0x | 4.6% | Software - Application | Track D | active | 2026-05-08 | 103 | — | — | 📰 | 18% | 60 C77 · M64 · E100 · H48 FADES | — |
GPCR |
$41.40 | $53.53 | -0.43% | +29.3% | -3.7% | 0.6M | 1.1x | 4.7% | Biotechnology | featured-tier-3 | removed | 2026-05-07 | 104 | ● on deck Aleniglipron+amylin combo data presented at ADA Jun 2026 (Phase 2 OLE 16.2% weight loss confirmed, published Nature Medicine); positive FDA EoP2 feedback received; Phase 3 program initiation Q3 2026 2026-09-30 |
Auto-graduated 2026-06-18: ran +50% from pivot $30.0 -> $45.0. Original: Oral GLP-1 player. Phase 2 readout in Q2 is the binary. | 📰 | 18% | 13 C90 · M68 · E58 · H82 | 2026-11-05 · 78d |
CDE |
$14.35 | $18.51 | -4.14% | +29.0% | -5.8% | 38.5M | 1.0x | 5.6% | Gold | Agent | active | 2026-07-18 | 32 | — | — | 📰 | — | 51 C34 · M81 · E43 · H53 FADES | 2026-10-28 · 70d |
BLKB⚠ TRAP |
$34.97 | $44.36 | +2.24% | +26.9% | -7.1% | 0.4M | 0.5x | 5.5% | Software - Application | Track D | removed | 2026-05-07 | 104 | — | — | 📰 | 19% | 23 C70 · M86 · E14 · H22 | 2026-10-28 · 70d |
BRZE |
$23.36 | $29.12 | +4.19% | +24.7% | -3.7% | 3.3M | 1.6x | 5.4% | Software - Application | Track D | active | 2026-05-29 | 82 | — | — | 📰 | — | 61 C57 · M84 · E21 · H94 FADES | 2026-09-03 · 15d |
BWMN |
$34.70 | $42.53 | +0.38% | +22.6% | 0.0% | 0.4M | 0.8x | 3.8% | Engineering & Construction | Track D | active | 2026-05-07 | 104 | — | — | 📰 | 18% | 49 C8 · M100 · E71 · H6 | 2026-11-04 · 77d |
ACIW |
$43.39 | $52.17 | +0.08% | +20.2% | -8.5% | 1.0M | 0.9x | 4.2% | Software - Infrastructure | Track D | active | 2026-05-07 | 104 | — | — | 📰 | 19% | 10 C30 · M9 · E58 · H44 HOLDS | 2026-11-05 · 78d |
USAR |
$15.86 | $18.51 | -4.04% | +16.7% | -9.7% | 8.6M | 0.7x | 7.7% | Other Industrial Metals & Mining | featured-tier-2 | removed | 2026-08-04 | 15 | ● on deck Dept of Commerce Letter of Intent Jan 2026 ($1.6B funding + ~10% equity at $17.17/share); Q2 2026 earnings mid-August + Stillwater OK magnet-production ramp updates 2026-08-20 |
Removed by research agent 2026-08-09: Popped +64% past pivot ($13.50 → $19.33 on Aug 7) on Serra Verde $2.8B Pela Ema mine tie-up + shareholder vote Aug 28. Graduated. Watch for re-add if it pulls back and re-bases $14-16 post-merger vote. | 📰 | — | 73 C73 · M82 · E71 · H47 | 2026-11-05 · 78d |
UUUU |
$12.15 | $14.09 | -4.73% | +16.0% | -8.3% | 6.1M | 0.9x | 6.5% | Uranium | featured-tier-2 | active | 2026-08-04 | 15 | ● on deck Q2 delivered Aug 5 (rev $25.1M vs $4.2M YoY, 865k lbs U3O8 production); VAC $1.9B rare-earth acquisition NOT expected to close until early 2027; White Mesa Mill heavy-REE plant construction underway; Q3 2026 earnings early Nov 2026-11-15 |
— | 📰 | — | 66 C51 · M73 · E43 · H69 | 2026-11-02 · 75d |
KTOS |
$53.47 | $61.99 | -2.05% | +15.9% | -7.6% | 2.8M | 0.7x | 6.3% | Aerospace & Defense | featured-tier-2 | removed | 2026-05-20 | 91 | ● catalyst fired Q2 2026 earnings + Valkyrie production ramp (8 to 40/yr) on $231.5M Marine Corps PoR contract; $446.8M Space Force missile warning contract Apr 8; FY26 revenue guide $1.6-1.7B 2026-08-06 |
Removed by research agent 2026-07-05: Ran from $52.09 setup to $58.53 (+12%) approaching pivot $60 on JPM Overweight $82 + Wedbush Outperform $85 initiations. Base compression / dry volume / RSI 40-65 no longer hold; entered pop phase. | 📰 | — | 57 C62 · M95 · E31 · H38 | 2026-11-03 · 76d |
SDGR |
$15.28 | $17.67 | +1.55% | +15.6% | -8.2% | 0.8M | 0.8x | 4.6% | Health Information Services | featured-tier-2 | removed | 2026-07-28 | 22 | ● catalyst fired Q2 2026 earnings Aug 5 AMC — AI+physics platform drug-discovery revenue (+124% YoY in Q1) + Ajax $2.3B sale mark 2026-08-05 |
Removed by research agent 2026-08-09: Q2 Aug 5 blew doors off — rev $58.9M vs $48M est, EPS +$0.08 vs -$0.49 est, FY26 drug-discovery guide raised. Stock popped to $16.41, past pivot $15.20. Graduated. | 📰 | — | 16 C36 · M79 · E43 · H23 | 2026-11-04 · 77d |
ATEX⚠ TRAP |
$81.44 | $90.75 | -0.90% | +11.4% | -4.3% | 0.4M | 1.0x | 8.1% | Telecom Services | Agent | active | 2026-06-12 | 68 | — | — | 📰 | — | 58 C53 · M29 · E81 · H52 | 2026-11-11 · 84d |
BMNR⚠ TRAP |
$16.63 | $18.28 | -2.40% | +9.9% | -5.3% | 20.4M | 0.7x | 5.3% | Capital Markets | Track H | removed | 2026-07-21 | 29 | — | — | 📰 | — | 42 C95 · M61 · E5 · H19 | 2026-11-20 · 93d |
SMR |
$7.96 | $8.64 | -5.98% | +8.5% | -14.8% BOUNCE ZONE | 27.9M | 0.9x | 8.0% | Specialty Industrial Machinery | featured-tier-2 | active | 2026-07-21 | 29 | ● on deck Q2 delivered Aug 5 (rev miss but $1.9B liquidity built); TVA/ENTRA1 discussions active with proposed 6-8 GW deployment; sole NRC-approved SMR standard design; Q3 2026 earnings early Nov + TVA PPA signing are dual catalysts 2026-11-05 |
— | 📰 | — | 77 C82 · M44 · E43 · H55 | 2026-11-05 · 78d |
TEM |
$46.18 | $49.36 | -4.42% | +6.9% | -13.4% BOUNCE ZONE | 3.5M | 0.7x | 6.5% | Health Information Services | featured-tier-2 | removed | 2026-05-26 | 85 | ● catalyst fired Q2 earnings July 30 2026; FDA xT CDx tumor-only approval delivered May 28-29 (+10%), first CDx approval for both tumor-only AND tumor-normal profiling; $400M 0% convertible 2032 priced; BMS 5-program collab May 14; FY26 guide raised to $1.59-1.60B 2026-07-30 |
Removed by research agent 2026-08-02: Q2 print landed Jul 30 with rev in-line + EPS beat + raised FY guide + $1.5B Personalis M&A announced. Binary catalyst is now behind it; further upside is a fundamentals story, not a pre-rally setup. Can re-enter if tightening/RS filter re-triggers. | 📰 | — | 43 C29 · M45 · E18 · H29 | 2026-11-03 · 76d |
AIRO |
$8.44 | $8.98 | -4.57% | +6.4% | -23.8% BOUNCE ZONE | 0.7M | 1.2x | 8.8% | Aerospace & Defense | featured-tier-2 | active | 2026-06-09 | 71 | ● on deck Q2 2026 BEAT delivered Aug 14 (rev $43.2M +76% YoY, gross margin 64%, drone backlog $163M, Blue UAS cert on RQ-35 confirmed); next catalyst = Q3 2026 earnings + RQ-70 full production Jan 2027 2026-11-14 |
— | 📰 | — | 84 C1 · M99 · E94 · H62 FADES | 2026-11-13 · 86d |
CAI⚠ TRAP |
$19.84 | $20.97 | -3.05% | +5.7% | -11.4% | 3.5M | 0.7x | 5.5% | Biotechnology | Track G | removed | 2026-05-08 | 103 | — | — | 📰 | — | 34 C19 · M90 · E43 · H31 | 2026-11-04 · 77d |
VKTX |
$32.12 | $33.37 | -0.77% | +3.9% | -4.2% | 1.2M | 0.6x | 4.0% | Biotechnology | featured-tier-1 | removed | 2026-05-07 | 104 | ● on deck SC Phase 3 primary readouts pushed to 2027 (VANQUISH-1 4,650pt enrolled Nov 2025; VANQUISH-2 1,000pt enrolled Mar 2026); nearer-term gates = VK2735 maintenance-dosing Phase 2 data Q3 2026 + oral VK2735 Phase 3 initiation Q4 2026; Big Pharma M&A speculation persists 2026-09-30 |
Removed by research agent 2026-08-16: VK2735 oral Phase 2 (VENTURE-2) delivered 12.2% weight loss at 13 weeks BUT 38% dropout at effective dose = harsh tolerability surprise; stock -37% pre-market. Near-term thesis materially damaged. SC Phase 3 VANQUISH readouts pushed to 2027 — outside the pattern's 3-6 month catalyst window. | 📰 | 20% | 3 C97 · M25 · E14 · H17 HOLDS | 2026-10-28 · 70d |
RXRX |
$3.01 | $3.09 | -0.64% | +2.7% | -9.6% | 16.2M | 1.1x | 4.9% | Biotechnology | featured-tier-3 | active | 2026-07-28 | 22 | ● on deck Q2 delivered Aug 5 (Genentech advanced first neuroscience target into joint discovery; REC-4881 Phase 2 delivered 43% median polyp burden reduction); cash runway to early 2028; next = additional REC-4881 Phase 2 data at CGA-IGC plenary Nov 2026 2026-11-05 |
— | 📰 | — | 35 C91 · M39 · E43 · H86 FADES | 2026-11-04 · 77d |
BL |
$29.81 | $30.23 | +3.17% | +1.4% | -5.0% | 0.8M | 0.7x | 6.0% | Software - Application | Track D | active | 2026-05-19 | 92 | — | — | 📰 | — | 39 C40 · M32 · E31 · H43 | 2026-11-03 · 76d |
BMRN |
$67.36 | $66.99 | +0.53% | -0.5% | -5.6% | 1.8M | 0.8x | 3.3% | Biotechnology | Track H | active | 2026-08-15 | 4 | — | — | 📰 | — | 26 C12 · M75 · E58 · H35 | 2026-10-26 · 68d |
ACHR |
$6.36 | $6.32 | -1.10% | -0.6% | -13.3% BOUNCE ZONE | 30.5M | 0.7x | 8.5% | Aerospace & Defense | featured-tier-1 | removed | 2026-05-26 | 85 | ● on deck First eVTOL company to enter FAA Phase 4 of 4 Type Certification; first US passenger-carrying flights targeted 2026 under White House eVTOL Integration Pilot Program ahead of LA28 Olympics; UAE Restricted Type Certificate pathway active with Abu Dhabi Aviation; $1.78B liquidity removes dilution overhang 2026-11-30 |
Removed by research agent 2026-07-05: Trading at $4.68 below setup entry $6.14 AND below 52w low $4.80; commercialization now 'likely by 2028' per Q1 update; binary-in-next-3-6-months gate broken. Structural re-drawdown, not a coil. | 📰 | — | 82 C9 · M87 · E71 · H13 FADES | 2026-11-05 · 78d |
ATEN |
$26.80 | $26.60 | -2.74% | -0.7% | -16.1% BOUNCE ZONE | 0.7M | 0.5x | 5.1% | Software - Infrastructure | Track D | active | 2026-05-07 | 104 | — | — | 📰 | 20% | 9 C14 · M6 · E43 · H9 HOLDS | 2026-11-03 · 76d |
ARLO |
$13.59 | $13.38 | -2.41% | -1.5% | -19.4% BOUNCE ZONE | 1.0M | 0.7x | 5.6% | Building Products & Equipment | Track A | active | 2026-05-12 | 99 | — | — | 📰 | 17% | 12 C26 · M30 · E58 · H14 HOLDS | 2026-11-05 · 78d |
ONDS |
$9.21 | $9.06 | +0.67% | -1.6% | -9.3% | 78.1M | 0.8x | 7.7% | Communication Equipment | featured-tier-3 | removed | 2026-05-07 | 104 | ● catalyst fired Q2 2026 earnings Aug 13 BMO (>$150M orders telegraphed) + Cyberhawk $125M acquisition close 2026-08-13 |
Removed by research agent 2026-08-16: Q2 catalyst delivered massive (rev $83.8M +13x YoY, $175M new orders, pro forma backlog $757M incl. DZYNE + Cyberhawk, raised FY outlook). Pre-catalyst basing thesis has played out; stock was already +150% 1Y entering the print. Runners can hold but the watchlist role — front-running the earnings coil — is complete. | 📰 | 15% | 91 C81 · M83 · E94 · H66 FADES | 2026-11-12 · 85d |
NNE |
$18.57 | $18.25 | -6.84% | -1.7% | -13.6% BOUNCE ZONE | 1.9M | 0.9x | 7.2% | Specialty Industrial Machinery | featured-tier-3 | active | 2026-08-11 | 8 | ● on deck Q3 FY26 business update delivered Aug 12 ($580M cash, STS acquisition closed, AFWERX SBIR Phase I + Direct-to-Phase-II pending, Supermicro AI datacenter MOU signed); next = Q4 FY26 business update webcast + further AFWERX / sovereign wealth updates 2026-11-15 |
— | 📰 | — | 70 C79 · M47 · E87 · H70 FADES | 2026-12-17 · 120d |
CENX |
$46.55 | $45.66 | -3.10% | -1.9% | -17.8% BOUNCE ZONE | 2.1M | 1.1x | 6.5% | Aluminum | Agent | active | 2026-06-30 | 50 | — | — | 📰 | — | 55 C32 · M43 · E58 · H68 | 2026-11-05 · 78d |
VERA |
$33.25 | $32.28 | +2.06% | -2.9% | -1.3% | 1.0M | 0.5x | 5.5% | Biotechnology | featured-tier-2 | removed | 2026-05-20 | 91 | ● catalyst fired Atacicept BLA — FDA Priority Review accepted, PDUFA July 7 2026 (~7 weeks); accelerated approval pathway for IgA Nephropathy; commercial launch on track for mid-2026 if approved 2026-07-07 |
Removed by research agent 2026-07-05: PDUFA July 7 is 2 days away — coil-into-binary pattern exhausted post-event regardless of outcome; removes from pre-run watchlist per framework 3-6 month binary window rule. | 📰 | — | 32 C45 · M53 · E71 · H8 HOLDS | 2026-11-05 · 78d |
AAON |
$84.87 | $82.06 | -6.85% | -3.3% | -15.8% BOUNCE ZONE | 1.5M | 1.2x | 6.8% | Building Products & Equipment | Agent | active | 2026-07-30 | 20 | — | — | 📰 | — | 47 C31 · M16 · E71 · H88 | 2026-11-05 · 78d |
RCAT |
$10.59 | $10.20 | -2.25% | -3.7% | -6.9% | 9.0M | 0.9x | 8.6% | Aerospace & Defense | featured-tier-2 | removed | 2026-05-07 | 104 | ● catalyst fired Japan MoD Black Widow order (173 units, JFY2026); U.S. Army Threat Analysis Kit partnership with Safe Pro Group (Jun 2 2026); HC Wainwright Buy $20 PT, Roth Buy $25 PT; Quaze acquisition closed May 20; Q2 print Aug 7 2026-08-07 |
Removed by research agent 2026-07-19: Graduated — trading ~$25.85 vs setup $11.00 = +135%, well past the +50% auto-graduate threshold. Black Widow catalyst played out (multi-Asia-Pacific ally orders, Q1 revenue +849%, Buy PTs at $19.60-$40). Clean pop; Aug 7 Q2 print is now post-pop, not a coiled entry. | 📰 | 15% | 86 C52 · M91 · E58 · H81 FADES | 2026-11-05 · 78d |
AMBQ |
$65.59 | $63.01 | -7.15% | -3.9% | -8.5% | 0.4M | 0.8x | 7.5% | Semiconductors | Track D | active | 2026-08-13 | 6 | — | — | 📰 | — | 71 C83 · M23 · E81 · H74 | 2026-11-05 · 78d |
ADEA |
$29.88 | $28.02 | -5.56% | -6.2% | -7.9% | 1.3M | 1.1x | 6.9% | Software - Application | Track G | removed | 2026-05-16 | 95 | — | — | 📰 | — | 52 C69 · M49 · E25 · H73 | 2026-11-02 · 75d |
KDK |
$4.29 | $4.01 | -3.37% | -6.5% | -13.8% BOUNCE ZONE | 1.0M | 1.0x | 7.6% | Software - Infrastructure | featured-tier-3 | active | 2026-07-21 | 29 | ● on deck Q2 delivered Aug 6 (rev $3.5M +91% QoQ, 35 driverless trucks, 40k+ paid hours, Gen7 platform launched, 91% long-haul autonomous readiness); next catalysts = Q3 2026 earnings + targeted long-haul driverless launch by YE 2026 2026-11-06 |
— | 📰 | — | 8 C55 · M22 · E58 · H40 HOLDS | 2026-11-05 · 78d |
ABUS |
$5.18 | $4.84 | +2.76% | -6.6% | -0.2% | 1.4M | 1.1x | 3.5% | Biotechnology | Agent | active | 2026-07-08 | 42 | — | — | 📰 | — | 22 C88 · M65 · E87 · H84 | 2026-11-16 · 89d |
STUB |
$7.63 | $7.13 | +0.14% | -6.6% | -11.8% | 6.8M | 1.1x | 7.9% | Internet Content & Information | featured-tier-2 | removed | 2026-05-07 | 104 | ● catalyst fired Anthropic Claude AI integration traction (live since Apr 2026); FIFA World Cup ~4% revenue tailwind; Q2 print (NOTE: prior June lockup catalyst was incorrect — actual lockup expired Mar 6 2026) 2026-08-12 |
Auto-graduated 2026-07-07: ran +52% from pivot $9.0 -> $13.69. Original: Post-IPO base study. $23.50 IPO -> $5.74 low -> $7.60 today. AI agent partnershi | 📰 | 17% | 44 C13 · M8 · E87 · H18 HOLDS | 2026-11-12 · 85d |
SWBI |
$15.24 | $14.17 | +0.14% | -7.0% | -18.3% BOUNCE ZONE | 0.4M | 1.0x | 2.3% | Aerospace & Defense | Track A | active | 2026-05-27 | 84 | — | — | 📰 | — | 1 C94 · M21 · E21 · H27 HOLDS | 2026-09-03 · 15d |
CDNL |
$49.65 | $45.14 | +15.07% | -9.1% | -0.4% | 1.5M | 1.9x | 12.2% | Engineering & Construction | Agent | active | 2026-05-28 | 83 | — | — | 📰 | — | 88 C5 · M5 · E81 · H97 FADES | 2026-11-12 · 85d |
AMPX |
$11.81 | $10.71 | -7.51% | -9.3% | -20.2% BOUNCE ZONE | 5.2M | 0.8x | 9.0% | Electrical Equipment & Parts | featured-tier-3 | active | 2026-08-11 | 8 | ● on deck Q2 delivered Aug 6 BEAT (rev $34M vs $29.3M est, raised FY26 guide to $140M+, Nanotech Energy US manufacturing partnership); next = Q3 2026 earnings early Nov + continued Replicator Program demand ramp 2026-11-06 |
— | 📰 | — | 78 C68 · M51 · E31 · H57 | 2026-11-05 · 78d |
KEEL |
$3.53 | $3.16 | -16.18% | -10.5% | -19.4% BOUNCE ZONE | 71.6M | 2.1x | 14.1% | Capital Markets | featured-tier-1 | removed | 2026-05-07 | 104 | ● on deck Washington 18MW HPC/AI conversion under $128M binding deal targets Dec 2026. Full exit from bitcoin mining. 2026-12-31 |
Auto-graduated 2026-05-08: ran +60% from pivot. Rebrand from Bitfarms to Keel Infrastructure COMPLETE Apr 2026 (BITF delisted, now trades as KEEL on Nasdaq + TSX). | 📰 | — | 92 C21 · M12 · E71 · H100 FADES | 2026-11-09 · 82d |
MO |
$73.09 | $65.19 | +1.92% | -10.8% | -15.4% BOUNCE ZONE | 9.7M | 1.0x | 3.0% | Tobacco | Agent | active | 2026-05-16 | 95 | — | — | 📰 | — | 21 C10 · M18 · E18 · H51 HOLDS | 2026-10-29 · 71d |
CALX |
$44.06 | $39.16 | -0.91% | -11.1% | -4.2% | 0.5M | 0.4x | 3.4% | Software - Infrastructure | Track D | active | 2026-05-07 | 104 | — | — | 📰 | 18% | 5 C84 · M55 · E6 · H16 HOLDS | 2026-10-26 · 68d |
BKV |
$30.07 | $26.65 | +1.14% | -11.4% | -1.4% | 0.9M | 1.0x | 3.6% | Oil & Gas E&P | Track H | active | 2026-05-07 | 104 | — | — | 📰 | — | 29 C39 · M62 · E58 · H34 | 2026-11-10 · 83d |
AXTI |
$95.97 | $82.31 | -14.23% | -14.2% | -15.8% BOUNCE ZONE | 15.6M | 1.2x | 15.4% | Semiconductor Equipment & Materials | Agent | active | 2026-08-18 | 1 | — | — | 📰 | — | 100 C25 · M97 · E18 · H91 FADES | 2026-10-29 · 71d |
IVA |
$5.45 | $4.64 | -1.28% | -14.9% | -6.1% | 0.8M | 1.1x | 4.6% | Biotechnology | featured-tier-2 | active | 2026-05-07 | 104 | ● on deck NATiV3 Phase 3 topline NARROWED to Q4 2026 (was H2 2026); trial over-enrolled for primary cohort; €166.1M cash + €67.8M short-term deposits + €130M BlackRock/Claret financing = dilution-free into readout 2026-12-15 |
— | 📰 | 15% | 6 C99 · M48 · E3 · H79 | 2026-09-25 · 37d |
NTGR |
$26.09 | $22.12 | -2.17% | -15.2% | -14.5% BOUNCE ZONE | 0.3M | 0.8x | 4.5% | Communication Equipment | Track A | active | 2026-05-27 | 84 | — | — | 📰 | — | 18 C60 · M27 · E58 · H45 HOLDS | 2026-10-28 · 70d |
ABTC⚠ TRAP |
$8.49 | $6.94 | -2.53% | -18.3% | -9.8% | 0.8M | 0.6x | 8.6% | Capital Markets | Track G | removed | 2026-07-07 | 43 | — | — | 📰 | — | 40 C66 · M52 · E25 · H4 HOLDS | 2026-11-05 · 78d |
CLSK |
$14.45 | $11.73 | -5.40% | -18.8% | -6.5% | 16.7M | 0.8x | 10.2% | Capital Markets | featured-tier-1 | removed | 2026-05-07 | 104 | ● catalyst fired Hyperscaler customer announcement still in advanced talks (live binary; neocloud also engaged); 585MW ERCOT-approved capacity; Q3 print Aug 6 2026-08-06 |
Removed by research agent 2026-07-26: Hyperscaler pre-rally pattern paid out — $6.6B (potential $11.6B) 20-year Sandersville lease announced July 15-21, 2026 with additional Texas 885 MW LOI. Stock moved to ~$15.61 with analyst PT parade ($26-$27 from Citizens/Cantor/Needham/B. Riley). Feature H (hyperscaler tell) has fired; move to Signal Tracker as graduated setup. | 📰 | 19% | 79 C42 · M14 · E58 · H39 | 2026-11-24 · 97d |
AVEX |
$24.61 | $19.91 | -1.53% | -19.1% | -15.7% BOUNCE ZONE | 1.1M | 0.7x | 8.8% | Aerospace & Defense | Agent | active | 2026-06-05 | 75 | — | — | 📰 | — | 65 C86 · M88 · E87 · H58 FADES | 2026-11-12 · 85d |
NXE |
$12.80 | $10.26 | -4.56% | -19.8% | -8.9% | 5.4M | 1.0x | 4.8% | Uranium | featured-tier-2 | active | 2026-05-07 | 104 | ● on deck CNSC federal license received Mar 2026; contracted volumes now 11.3Mlb; Sept 1 2026 detailed Rook I construction webinar is next major catalyst; 20Mlb additional offtake in discussion for H2 2026 2026-09-01 |
— | 📰 | 18% | 53 C56 · M92 · E43 · H96 | 2026-11-03 · 76d |
ASST⚠ TRAP |
$16.03 | $12.80 | -3.03% | -20.1% | -4.7% | 3.9M | 1.5x | 5.8% | Asset Management | Track H | removed | 2026-05-07 | 104 | — | — | 📰 | 15% | 48 C96 · M56 · E71 · H87 FADES | 2026-11-10 · 83d |
MRAM |
$23.66 | $18.45 | -7.05% | -22.0% | -8.4% | 2.0M | 1.5x | 8.6% | Semiconductors | Track A | active | 2026-06-06 | 74 | — | — | 📰 | — | 94 C71 · M69 · E43 · H99 FADES | 2026-11-11 · 84d |
AMRC |
$32.73 | $25.49 | -10.56% | -22.1% | -11.6% | 0.9M | 1.3x | 9.1% | Engineering & Construction | Track A | removed | 2026-06-05 | 75 | — | — | 📰 | — | 81 C27 · M70 · E25 · H95 FADES | 2026-11-02 · 75d |
BTBT |
$1.88 | $1.45 | -9.37% | -22.9% | -8.8% | 24.9M | 1.1x | 8.1% | Capital Markets | featured-tier-3 | active | 2026-05-07 | 104 | ● on deck Q2 2026 BEAT delivered Aug 13 (rev $32.1M vs $24.2M est, cloud services +42% QoQ, WhiteFiber $540M+ new multi-year contracts); next catalyst = Q3 2026 earnings + WhiteFiber NC-1 data center campus milestones 2026-11-13 |
— | 📰 | 15% | 87 C65 · M40 · E94 · H90 FADES | 2026-11-12 · 85d |
GLSI |
$23.13 | $17.26 | -0.69% | -25.4% | -2.8% | 0.1M | 0.8x | 6.8% | Biotechnology | featured-tier-2 | active | 2026-05-07 | 104 | ● on deck Insider lock-up EXTENDED to January 31, 2027 (announced Aug 10 2026) — bigger smart-money positioning tell than prior Sept expiry; FLAMINGO-01 UK expansion approved Jul 22 adds 5-10 sites; further FLAMINGO-01 immune-response data cuts H2 2026 2027-01-31 |
— | 📰 | 20% | 64 C74 · M74 · E81 · H25 HOLDS | 2026-11-12 · 85d |
JOBY |
$10.27 | $7.65 | -3.29% | -25.5% | -15.7% BOUNCE ZONE | 17.6M | 0.5x | 6.8% | Airports & Air Services | featured-tier-1 | active | 2026-05-07 | 104 | ● on deck FAA Stage 4 cleared March 2026; TIA flight testing underway; commercial launch with Delta target late 2026; Type Certificate issuance estimated late 2026 2026-11-30 |
— | 📰 | 15% | 30 C58 · M38 · E43 · H10 HOLDS | 2026-11-04 · 77d |
SMMT |
$17.80 | $12.82 | +0.31% | -28.0% | -18.6% BOUNCE ZONE | 4.6M | 1.0x | 6.2% | Biotechnology | featured-tier-1 | removed | 2026-05-07 | 104 | ● catalyst fired HARMONi-6 OS data ASCO Plenary; PDUFA Nov 14 2026 2026-05-31 |
Cut 2026-06-09 (monthly review): near catalyst FIRED weak — HARMONi-6 OS data at ASCO Plenary (May 31) was positive but sold the news; -18.5% from first scan ($17.80). Fired-catalyst weakness; next binary (EGFR-mut PDUFA Nov 14) too far to hold through the drawdown. Tracking since-removal. | 📰 | 16% | 45 C35 · M42 · E8 · H36 | 2026-10-19 · 61d |
SHLS |
$10.82 | $7.68 | -6.68% | -29.0% | -15.1% BOUNCE ZONE | 5.7M | 1.1x | 8.5% | Solar | Track A | removed | 2026-05-27 | 84 | — | — | 📰 | — | 36 C75 · M10 · E31 · H65 | 2026-11-03 · 76d |
ASPI⚠ TRAP |
$5.50 | $3.86 | -3.98% | -29.8% | -11.7% | 3.3M | 0.9x | 7.1% | Chemicals | Track H | removed | 2026-05-07 | 104 | — | — | 📰 | 15% | 25 C92 · M26 · E99 · H49 HOLDS | 2026-11-12 · 85d |
APLD |
$43.28 | $28.51 | -8.56% | -34.1% | -13.7% BOUNCE ZONE | 17.5M | 0.9x | 8.9% | Information Technology Services | Track H | active | 2026-05-07 | 104 | — | — | 📰 | 20% | 75 C87 · M36 · E10 · H75 FADES | 2026-10-08 · 50d |
LUMN |
$9.56 | $6.13 | -6.84% | -35.9% | -9.9% | 9.1M | 0.6x | 6.9% | Telecom Services | featured-tier-2 | active | 2026-05-07 | 104 | ● on deck Q2 2026 print delivered Jul 30; forward catalyst = Q3 2026 earnings + continued AI/hyperscaler PCF backlog conversions ($13B PCF backlog) 2026-10-30 |
— | 📰 | 19% | 38 C48 · M31 · E31 · H64 HOLDS | 2026-10-29 · 71d |
AOSL |
$45.35 | $28.38 | -8.66% | -37.4% | -23.3% BOUNCE ZONE | 0.6M | 1.0x | 9.7% | Semiconductors | Track A | active | 2026-05-30 | 81 | — | — | 📰 | — | 74 C44 · M17 · E87 · H78 | 2026-11-09 · 82d |
BTDR |
$14.85 | $9.00 | -4.15% | -39.4% | -7.2% | 20.9M | 1.6x | 13.3% | Software - Application | featured-tier-2 | active | 2026-05-07 | 104 | ● on deck Q2 2026 miss delivered Aug 10 (rev $228.8M but EPS -$0.39 vs -$0.34 est, stock -15%); next catalyst = Q3 2026 earnings + Nevada assembly plant / Norway Tydal AI datacenter execution milestones 2026-11-10 |
— | 📰 | 15% | 95 C18 · M19 · E71 · H71 | 2026-11-09 · 82d |
BW |
$15.49 | $9.14 | -7.86% | -41.0% | -13.8% BOUNCE ZONE | 5.2M | 1.1x | 12.0% | Specialty Industrial Machinery | Track D | active | 2026-06-10 | 70 | — | — | 📰 | — | 83 C23 · M35 · E71 · H60 | 2026-11-03 · 76d |
SEDG |
$51.75 | $29.82 | -3.15% | -42.4% | -15.2% BOUNCE ZONE | 4.3M | 1.2x | 11.4% | Solar | Track A | removed | 2026-06-27 | 53 | — | — | 📰 | — | 69 C17 · M4 · E43 · H26 HOLDS | 2026-11-04 · 77d |
ARRY |
$8.42 | $4.80 | -3.61% | -43.0% | -24.1% BOUNCE ZONE | 5.5M | 0.8x | 8.2% | Solar | Track A | active | 2026-05-27 | 84 | — | — | 📰 | — | 27 C43 · M13 · E43 · H21 HOLDS | 2026-11-04 · 77d |
BLSH |
$43.86 | $24.62 | -1.36% | -43.9% | -12.8% BOUNCE ZONE | 0.9M | 0.6x | 6.2% | Software - Infrastructure | featured-tier-3 | removed | 2026-05-07 | 104 | ● on deck Equiniti $4.2B definitive agreement signed May 5 2026 ($1.85B debt + $2.35B BLSH stock at $38.48 VWAP); close moved to Jan 2027 2027-01-31 |
Cut 2026-06-09 (monthly review): Equiniti deal close slipped to Jan 2027 — catalyst window now far out; -36% from first scan ($43.86), worst Featured Tier-3 performer. Demoted; tracking since-removal. | 📰 | 18% | 56 C38 · M66 · E94 · H30 | 2026-11-12 · 85d |
BRUN |
$36.74 | $20.13 | -11.05% | -45.2% | -11.6% | 1.9M | 0.8x | 12.8% | Software - Infrastructure | Track G | active | 2026-06-03 | 77 | — | — | 📰 | — | 96 C16 · M60 · E3 · H61 | 2026-11-16 · 89d |
TDUP |
$5.86 | $2.81 | -1.75% | -52.0% | -9.5% | 2.5M | 0.8x | 16.6% | Internet Retail | featured-tier-3 | removed | 2026-07-28 | 22 | ● catalyst fired Q2 2026 earnings — order acceleration (Q1 +19.3% YoY to 1.6M) + AI image-search moat 2026-08-05 |
Removed by research agent 2026-08-09: Q2 Aug 5 broke the setup — FY26 revenue guide cut $353.7M → $346.4M, next-quarter guide 5.4% below estimates, stock dropped -15.5% on print. Distribution day + broken structure = thesis invalidated. | 📰 | — | 14 C6 · M1 · E43 · H5 HOLDS | 2026-11-02 · 75d |
CD⚠ TRAP |
$10.49 | $3.65 | +3.69% | -65.2% | -9.7% | 0.2M | 1.0x | 14.2% | Capital Markets | Track H | removed | 2026-05-19 | 92 | — | Cut 2026-06-09 (monthly review): auto-detected only, already dropped from scanning; -53% from first scan ($10.49) — worst name on the list. Crypto-tokenization promote with no near-term revenue path, catalyst tagged far, trap-risk high. Hard cut; tracking since-removal. | 📰 | — | 62 C22 · M57 · E3 · H42 HOLDS | — |
CAPR |
$22.43 | $7.08 | -4.97% | -68.4% | -14.6% BOUNCE ZONE | 8.4M | 0.8x | 14.6% | Biotechnology | featured-tier-2 | removed | 2026-07-07 | 43 | ● on deck AdCom Jul 29 voted 3-9 AGAINST deramiocel; PDUFA target action Aug 22 (non-binding vote — high-risk binary, ~30% approval odds); position size accordingly 2026-08-22 |
Removed by research agent 2026-08-16: Pattern ripped +80.5% on Aug 14 on Cantor Fitzgerald upgrade to Overweight ($28 PT from $3.50) + Lancet publication of HOPE-3 data. Coil-into-catalyst trade is done — with AdCom having voted 3-9 against and PDUFA in 6 days (Aug 22), this is now a binary hold-through-approval bet, not a pattern trade. Reassess post-PDUFA. | 📰 | — | 99 C3 · M71 · E94 · H83 FADES | 2026-11-10 · 83d |
EVTL |
$2.66 | $0.78 | -3.29% | -70.7% | -22.3% BOUNCE ZONE | 3.8M | 0.4x | 17.4% | Aerospace & Defense | featured-tier-2 | removed | 2026-05-07 | 104 | ● on deck Post-Farnborough — CAA/EASA cert progression + UK grant firming + Near Earth Autonomy defense partnership expansion 2026-11-15 |
Removed by research agent 2026-08-16: Cert timeline officially slipped to 2029 (from 2028) at Farnborough — EVTL now trails JOBY/ACHR by at least a year. The cohort-laggard thesis worked when the gap was closing; the gap is widening. Near Earth Autonomy partnership + $100M financing keep the story alive but move the payoff window materially further out. | 📰 | 15% | 90 C4 · M3 · E94 · H1 HOLDS | 2026-11-03 · 76d |
| Symbol | Now $ | Theme | MCap | Pivot | vs Pivot | Status | Live | Cur. | Catalyst | Date | News |
|---|---|---|---|---|---|---|---|---|---|---|---|
JOBY Joby Aviation |
$7.65 | EVTOL | $8.5B | $10.00 | -23.5% | Basing | 6/10 | 9/12 | FAA Stage 4 cleared March 2026; TIA flight testing underway; commercial launch with Delta target late 2026; Type Certificate issuance estimated late 2026 | 2026-11-30 | 📰 |
| Symbol | Now $ | Theme | MCap | Pivot | vs Pivot | Status | Live | Cur. | Catalyst | Date | News |
|---|---|---|---|---|---|---|---|---|---|---|---|
BTDR Bitdeer ⚠ |
$9.00 | AI compute (BTC shift) | $3.4B | $15.00 | -40.0% | Broken | 2/10 | 8/12 | Q2 2026 miss delivered Aug 10 (rev $228.8M but EPS -$0.39 vs -$0.34 est, stock -15%); next catalyst = Q3 2026 earnings + Nevada assembly plant / Norway Tydal AI datacenter execution milestones | 2026-11-10 | 📰 |
LUMN Lumen Technologies ⚠ |
$6.13 | AI fiber backbone | $9.2B | $10.00 | -38.7% | Broken | 3/10 | 8/12 | Q2 2026 print delivered Jul 30; forward catalyst = Q3 2026 earnings + continued AI/hyperscaler PCF backlog conversions ($13B PCF backlog) | 2026-10-30 | 📰 |
NXE NexGen Energy |
$10.26 | Uranium (development) | $7.0B | $13.50 | -24.0% | Basing | 5/10 | 7/12 | CNSC federal license received Mar 2026; contracted volumes now 11.3Mlb; Sept 1 2026 detailed Rook I construction webinar is next major catalyst; 20Mlb additional offtake in discussion for H2 2026 | 2026-09-01 | 📰 |
GLSI Greenwich LifeSciences |
$17.26 | Oncology (HER2+ breast cancer immunotherapy) | $0.3B | $26.00 | -33.6% | Basing | 4/10 | 8/12 | Insider lock-up EXTENDED to January 31, 2027 (announced Aug 10 2026) — bigger smart-money positioning tell than prior Sept expiry; FLAMINGO-01 UK expansion approved Jul 22 adds 5-10 sites; further FLAMINGO-01 immune-response data cuts H2 2026 | 2027-01-31 | 📰 |
IVA Inventiva |
$4.64 | MASH/NASH biotech (lanifibranor) | $1.0B | $5.50 | -15.6% | Basing | 4/10 | 8/12 | NATiV3 Phase 3 topline NARROWED to Q4 2026 (was H2 2026); trial over-enrolled for primary cohort; €166.1M cash + €67.8M short-term deposits + €130M BlackRock/Claret financing = dilution-free into readout | 2026-12-15 | 📰 |
AIRO AIRO Group Holdings |
$8.98 | Defense drones / advanced air mobility (recent-IPO base) | $0.4B | $11.00 | -18.4% | Basing | 6/10 | 8/12 | Q2 2026 BEAT delivered Aug 14 (rev $43.2M +76% YoY, gross margin 64%, drone backlog $163M, Blue UAS cert on RQ-35 confirmed); next catalyst = Q3 2026 earnings + RQ-70 full production Jan 2027 | 2026-11-14 | 📰 |
SMR NuScale Power |
$8.64 | Nuclear (SMR) | $3.1B | $10.00 | -13.6% | Basing | 5/10 | 8/12 | Q2 delivered Aug 5 (rev miss but $1.9B liquidity built); TVA/ENTRA1 discussions active with proposed 6-8 GW deployment; sole NRC-approved SMR standard design; Q3 2026 earnings early Nov + TVA PPA signing are dual catalysts | 2026-11-05 | 📰 |
UUUU Energy Fuels |
$14.09 | Uranium + rare earth (dual play with Pentagon backing) | $2.1B | $10.50 | +34.2% | Running | 5/10 | 8/12 | Q2 delivered Aug 5 (rev $25.1M vs $4.2M YoY, 865k lbs U3O8 production); VAC $1.9B rare-earth acquisition NOT expected to close until early 2027; White Mesa Mill heavy-REE plant construction underway; Q3 2026 earnings early Nov | 2026-11-15 | 📰 |
| Symbol | Now $ | Theme | MCap | Pivot | vs Pivot | Status | Live | Cur. | Catalyst | Date | News |
|---|---|---|---|---|---|---|---|---|---|---|---|
BTBT Bit Digital |
$1.45 | AI cloud + ETH treasury | $0.7B | $2.20 | -34.1% | Basing | 6/10 | 8/12 | Q2 2026 BEAT delivered Aug 13 (rev $32.1M vs $24.2M est, cloud services +42% QoQ, WhiteFiber $540M+ new multi-year contracts); next catalyst = Q3 2026 earnings + WhiteFiber NC-1 data center campus milestones | 2026-11-13 | 📰 |
KDK Kodiak AI |
$4.01 | Autonomous trucking / AI infra (post-IPO base) | $0.9B | $5.50 | -27.1% | Basing | 5/10 | 8/12 | Q2 delivered Aug 6 (rev $3.5M +91% QoQ, 35 driverless trucks, 40k+ paid hours, Gen7 platform launched, 91% long-haul autonomous readiness); next catalysts = Q3 2026 earnings + targeted long-haul driverless launch by YE 2026 | 2026-11-06 | 📰 |
RXRX Recursion Pharmaceuticals Inc ⚠ |
$3.09 | AI drug discovery | $1.4B | $6.80 | -54.6% | Broken | 6/10 | 8/12 | Q2 delivered Aug 5 (Genentech advanced first neuroscience target into joint discovery; REC-4881 Phase 2 delivered 43% median polyp burden reduction); cash runway to early 2028; next = additional REC-4881 Phase 2 data at CGA-IGC plenary Nov 2026 | 2026-11-05 | 📰 |
NNE NANO Nuclear Energy |
$18.25 | Nuclear microreactors (SMR small-cap pure-play) | $0.6B | $22.00 | -17.0% | Basing | 5/10 | 8/12 | Q3 FY26 business update delivered Aug 12 ($580M cash, STS acquisition closed, AFWERX SBIR Phase I + Direct-to-Phase-II pending, Supermicro AI datacenter MOU signed); next = Q4 FY26 business update webcast + further AFWERX / sovereign wealth updates | 2026-11-15 | 📰 |
AMPX Amprius Technologies |
$10.71 | Silicon-anode batteries (defense drone / Replicator Program) | $1.4B | $13.50 | -20.7% | Basing | 5/10 | 8/12 | Q2 delivered Aug 6 BEAT (rev $34M vs $29.3M est, raised FY26 guide to $140M+, Nanotech Energy US manufacturing partnership); next = Q3 2026 earnings early Nov + continued Replicator Program demand ramp | 2026-11-06 | 📰 |
tools/screener/featured_setups.json. Status: Basing = below pivot · Coiling = within 10% of pivot · Breaking Out = at/above pivot · Running = +10% past pivot · Broken (red bar) = price <= setup × 0.7. Auto-graduate at +50% from pivot — setup moves to Avoid list automatically. Hover any row for the qualitative thesis.
| Symbol | Price | Score | Features | Drawdown | Base wks | RSI | vs 50MA | vs 200MA | RelVol | Dist | PP | VCP | Track | News |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BW |
$9.14 | 7/10 | ACEFHIJ | 58% | 0 | 42 | -23% | -20% | 0.54 | 3 | ✓ | ✓ | D | 📰 |
CALX |
$39.16 | 7/10 | BCDEHIJ | 43% | 12 | 55 | +3% | -18% | 0.09 | 5 | · | ✓ | D | 📰 |
AAOI |
$131.41 | 7/10 | BEFGHIJ | 41% | 0 | 52 | -1% | +37% | 0.56 | 2 | ✓ | · | H | 📰 |
ALKT |
$20.14 | 7/10 | BCDFGIJ | 24% | 8 | 63 | +15% | +9% | 2.18 | 0 | ✓ | ✓ | D | 📰 |
MRAM |
$18.45 | 7/10 | ABCGHIJ | 58% | 0 | 54 | -3% | +23% | 2.88 | 2 | · | ✓ | A | 📰 |
BL |
$30.23 | 7/10 | BCDFHIJ | 49% | 11 | 51 | +4% | -24% | 2.76 | 3 | ✓ | ✓ | D | 📰 |
BILL |
$49.17 | 7/10 | CDFGHIJ | 13% | 5 | 60 | +19% | +12% | 2.42 | 0 | ✓ | ✓ | D | 📰 |
AMBQ |
$63.01 | 6/10 | CEFHIJ | 30% | 0 | 43 | -16% | +38% | 0.53 | 3 | ✓ | ✓ | D | 📰 |
AIRO |
$8.98 | 6/10 | ACDFGJ | 65% | 5 | 59 | +19% | -1% | 2.72 | 1 | ✓ | ✓ | B | 📰 |
SWBI |
$14.17 | 6/10 | BCEFGJ | 14% | 0 | 41 | -5% | +11% | 0.66 | 1 | ✓ | ✓ | A | 📰 |
TENB |
$36.34 | 6/10 | BFGHIJ | 15% | 0 | 52 | +7% | +42% | 0.86 | 2 | ✓ | · | A | 📰 |
ACIW |
$52.17 | 6/10 | BDEHIJ | 13% | 4 | 41 | -1% | +14% | 0.46 | 4 | · | · | D | 📰 |
| Symbol | Price | Score | Features | Drawdown | Base wks | RSI | vs 50MA | vs 200MA | RelVol | Dist | PP | VCP | Track | News |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMRN |
$66.99 | 5/10 | BDFGJ | 5% | 10 | 64 | +12% | +18% | 2.40 | 0 | ✓ | · | H | 📰 |
BRUN |
$20.13 | 5/10 | CFHIJ | 49% | 0 | 44 | -25% | +15% | 2.69 | 4 | ✓ | ✓ | G | 📰 |
APLD |
$28.51 | 5/10 | CGHIJ | 43% | 0 | 44 | -15% | -12% | 1.10 | 2 | · | ✓ | H | 📰 |
ABUS |
$4.84 | 5/10 | BCFGJ | 7% | 3 | 61 | +6% | +9% | 2.47 | 1 | ✓ | ✓ | H | 📰 |
BRZE |
$29.12 | 5/10 | FGHIJ | 20% | 0 | 61 | +21% | +19% | 2.94 | 2 | ✓ | · | D | 📰 |
NTGR |
$22.12 | 5/10 | BCDEG | 39% | 9 | 40 | -6% | -8% | 0.56 | 2 | · | ✓ | A | 📰 |
ARLO |
$13.38 | 5/10 | BDHIJ | 31% | 9 | 42 | -1% | -3% | 1.78 | 3 | · | · | A | 📰 |
BKV |
$26.65 | 5/10 | BCEGJ | 17% | 3 | 58 | +5% | -3% | 0.52 | 1 | · | ✓ | H | 📰 |
BWMN |
$42.53 | 5/10 | CDFHI | 4% | 8 | 85 | +40% | +31% | 0.95 | 3 | ✓ | ✓ | D | 📰 |
AXTI |
$82.31 | 4/10 | GHIJ | 42% | 0 | 57 | +20% | +61% | 1.47 | 2 | · | · | H | 📰 |
CENX |
$45.66 | 4/10 | BHIJ | 34% | 0 | 46 | -5% | -6% | 1.57 | 3 | · | · | D | 📰 |
ATEN |
$26.60 | 4/10 | EGHI | 30% | 0 | 33 | -19% | +10% | 0.44 | 2 | · | · | D | 📰 |
CDE |
$18.51 | 4/10 | BCGJ | 32% | 0 | 59 | +13% | 0% | 1.02 | 0 | · | ✓ | G | 📰 |
AVEX |
$19.91 | 4/10 | ACFJ | 51% | 3 | 53 | +9% | — | 2.84 | 3 | ✓ | ✓ | B | 📰 |
AOSL |
$28.38 | 4/10 | CFHI | 47% | 0 | 39 | -24% | -3% | 2.35 | 3 | ✓ | ✓ | A | 📰 |
ARRY |
$4.80 | 4/10 | ACDE | 60% | 4 | 35 | -25% | -41% | 0.63 | 3 | · | ✓ | A | 📰 |
| Symbol | Reason | News |
|---|---|---|
CIFR |
+522% 1Y - hyperscaler deal already consensus, not the tell | 📰 |
RIOT |
Multiple-fold this year; AMD deal priced in | 📰 |
BE |
+316% in 6mo - extended; chase risk | 📰 |
PLUG |
+236% 1Y; profitability 2 years out | 📰 |
POWL |
$54.75 -> $298 - setup-to-mania already done | 📰 |
MOD |
Near ATH $268; DC revenue already in numbers | 📰 |
CRWV |
$50 -> $187 -> $128 - past Stage 2, needs to base again | 📰 |
LWLG |
$0.83 -> $15.79 - base broke out 2025, chase now | 📰 |
LEU |
+313% YTD - HALEU re-rate happened | 📰 |
RKLB |
~+250% 1Y - past entry | 📰 |
RVMD |
Auto-graduated 2026-05-07: ran +211% from pivot $48.0 -> $149.09. Original: RAS oncology. Daraxonrasib Ph 3 PDAC readout in H1. | 📰 |
MRCY |
Removed by research agent 2026-05-07: Catalyst window closed: Q3 FY26 earnings reported May 5, 2026. Record backlog ($1.6B) and raised full-year guidance de-risk thesis, but binary event has fired. Recommend removal to maintain forward-looking watchlist focus. | 📰 |
POET |
Removed by research agent 2026-05-07: Marvell cancelled all outstanding purchase orders in early May 2026 alleging confidentiality breach. The 30K-unit revenue thesis hinged on customer validation — now in dispute. Thesis materially impaired pending replacement Tier-1 customer. | 📰 |
AVAV |
Removed by research agent 2026-05-07: Q2 FY26 missed (adj EPS $0.44 vs $0.81-0.87 cons); FY26 guide cut to $3.40-3.55 from $3.60-3.70; stock -30% since Oct. Backlog is converting but margins/EPS are breaking — pattern setup invalidated. | 📰 |
CRML |
Removed by research agent 2026-05-07: +717% 1Y vs +90% at setup. The pre-rally pattern has played out — Tanbreez 92.5% achieved, pilot plant constructed. Graduate to a 'former setup' monitor list rather than keep occupying a Tier 2 slot. | 📰 |
FLNC |
Removed by research agent 2026-05-07: Q1 margin collapse (gross 5.6% vs 12.5%; EBITDA -$52M miss). DC-pipeline narrative is intact but unit economics now look broken — base structure shifts from coiling to failing. Remove pending H2 margin recovery. | 📰 |
KEEL |
Auto-graduated 2026-05-08: ran +60% from pivot. Rebrand from Bitfarms to Keel Infrastructure COMPLETE Apr 2026 (BITF delisted, now trades as KEEL on Nasdaq + TSX). | 📰 |
ALOY |
Removed by research agent 2026-05-19: Sangdong Phase 1 reached commercial production in May 2026, Q1 revenue +221% YoY, tungsten APT prices +50% YTD — pre-rally setup has substantially completed. Remaining catalysts (Montana H2 2026, Phase 2 in 2027) are now ramp-execution rather than setup-into-binary. Stock trades ALM on NASDAQ at the equivalent of ~3x the $8 add price. | 📰 |
GPCR |
Auto-graduated 2026-06-18: ran +50% from pivot $30.0 -> $45.0. Original: Oral GLP-1 player. Phase 2 readout in Q2 is the binary. | 📰 |
ERAS |
Auto-graduated 2026-07-01: ran +65% from pivot $11.0 -> $18.17. Original: RAS-pathway oncology. Phase 1 readout in 1-2 weeks. 62% NSCLC RR is the headline | 📰 |
VERA |
Removed by research agent 2026-07-05: PDUFA July 7 is 2 days away — coil-into-binary pattern exhausted post-event regardless of outcome; removes from pre-run watchlist per framework 3-6 month binary window rule. | 📰 |
KTOS |
Removed by research agent 2026-07-05: Ran from $52.09 setup to $58.53 (+12%) approaching pivot $60 on JPM Overweight $82 + Wedbush Outperform $85 initiations. Base compression / dry volume / RSI 40-65 no longer hold; entered pop phase. | 📰 |
ACHR |
Removed by research agent 2026-07-05: Trading at $4.68 below setup entry $6.14 AND below 52w low $4.80; commercialization now 'likely by 2028' per Q1 update; binary-in-next-3-6-months gate broken. Structural re-drawdown, not a coil. | 📰 |
STUB |
Auto-graduated 2026-07-07: ran +52% from pivot $9.0 -> $13.69. Original: Post-IPO base study. $23.50 IPO -> $5.74 low -> $7.60 today. AI agent partnershi | 📰 |
RCAT |
Removed by research agent 2026-07-19: Graduated — trading ~$25.85 vs setup $11.00 = +135%, well past the +50% auto-graduate threshold. Black Widow catalyst played out (multi-Asia-Pacific ally orders, Q1 revenue +849%, Buy PTs at $19.60-$40). Clean pop; Aug 7 Q2 print is now post-pop, not a coiled entry. | 📰 |
CLSK |
Removed by research agent 2026-07-26: Hyperscaler pre-rally pattern paid out — $6.6B (potential $11.6B) 20-year Sandersville lease announced July 15-21, 2026 with additional Texas 885 MW LOI. Stock moved to ~$15.61 with analyst PT parade ($26-$27 from Citizens/Cantor/Needham/B. Riley). Feature H (hyperscaler tell) has fired; move to Signal Tracker as graduated setup. | 📰 |
TEM |
Removed by research agent 2026-08-02: Q2 print landed Jul 30 with rev in-line + EPS beat + raised FY guide + $1.5B Personalis M&A announced. Binary catalyst is now behind it; further upside is a fundamentals story, not a pre-rally setup. Can re-enter if tightening/RS filter re-triggers. | 📰 |
USAR |
Removed by research agent 2026-08-09: Popped +64% past pivot ($13.50 → $19.33 on Aug 7) on Serra Verde $2.8B Pela Ema mine tie-up + shareholder vote Aug 28. Graduated. Watch for re-add if it pulls back and re-bases $14-16 post-merger vote. | 📰 |
SDGR |
Removed by research agent 2026-08-09: Q2 Aug 5 blew doors off — rev $58.9M vs $48M est, EPS +$0.08 vs -$0.49 est, FY26 drug-discovery guide raised. Stock popped to $16.41, past pivot $15.20. Graduated. | 📰 |
TDUP |
Removed by research agent 2026-08-09: Q2 Aug 5 broke the setup — FY26 revenue guide cut $353.7M → $346.4M, next-quarter guide 5.4% below estimates, stock dropped -15.5% on print. Distribution day + broken structure = thesis invalidated. | 📰 |
CAPR |
Removed by research agent 2026-08-16: Pattern ripped +80.5% on Aug 14 on Cantor Fitzgerald upgrade to Overweight ($28 PT from $3.50) + Lancet publication of HOPE-3 data. Coil-into-catalyst trade is done — with AdCom having voted 3-9 against and PDUFA in 6 days (Aug 22), this is now a binary hold-through-approval bet, not a pattern trade. Reassess post-PDUFA. | 📰 |
ONDS |
Removed by research agent 2026-08-16: Q2 catalyst delivered massive (rev $83.8M +13x YoY, $175M new orders, pro forma backlog $757M incl. DZYNE + Cyberhawk, raised FY outlook). Pre-catalyst basing thesis has played out; stock was already +150% 1Y entering the print. Runners can hold but the watchlist role — front-running the earnings coil — is complete. | 📰 |
VKTX |
Removed by research agent 2026-08-16: VK2735 oral Phase 2 (VENTURE-2) delivered 12.2% weight loss at 13 weeks BUT 38% dropout at effective dose = harsh tolerability surprise; stock -37% pre-market. Near-term thesis materially damaged. SC Phase 3 VANQUISH readouts pushed to 2027 — outside the pattern's 3-6 month catalyst window. | 📰 |
EVTL |
Removed by research agent 2026-08-16: Cert timeline officially slipped to 2029 (from 2028) at Farnborough — EVTL now trails JOBY/ACHR by at least a year. The cohort-laggard thesis worked when the gap was closing; the gap is widening. Near Earth Autonomy partnership + $100M financing keep the story alive but move the payoff window materially further out. | 📰 |
| Group | Feature | Threshold | Auto? |
|---|---|---|---|
| Structural setup | 1. Drawdown depth | ≥50% off prior 2–3yr peak | ✓ (250d proxy) |
| 2. Stage 1→2 transition | Price near 50MA, 200MA flattening | ✓ | |
| 3. VCP — tightening volatility | ATR contracted ≥40% | ✓ | |
| 4. Within 25% of base low | Basing for ≥4 weeks | ✓ | |
| Volume signature | 5. Volume dry-up | RelVol < 0.7 of 90d avg | ✓ |
| 6. Pocket pivot | Up-day vol > max down-day vol last 10 | ✓ | |
| 7. No distribution | ≤2 distribution days last 40 | ✓ | |
| Catalyst on deck | 8. Binary event scheduled | FDA / contract / earnings <6mo | ✗ (Featured only) |
| 9. First hyperscaler contract | Recent 8-K + DC keyword density | ✓ (proxy) | |
| 10. Revenue inflection | Sequential growth turning positive | ✓ (RSI band proxy) | |
| Theme + positioning | 11. Hot-theme pure-play | DC/AI/HPC kw density | ✓ |
| 12. Smart-money positioning | 13F new pos / analyst init / Nvidia stake | ✗ (cross-ref Aschenbrenner Watch) |
Every name on this board is reviewed about once a month. When a setup's thesis breaks — its catalyst comes and goes without the move, slips far into the future, or its quality drops — the name is removed from the board and listed under Removed from Signal Tracker above.
A removal is not permanent. After about a month a removed name can earn its way back — but only if it forms a genuinely fresh setup and clears the screen again on its own. Nothing returns just because time has passed; it has to re-qualify.
We keep the full record — the winners and the names we cut — so the scoreboard stays honest instead of quietly dropping whatever didn't work.
Luna3.ai · Internal tool · Not financial advice